Reservoir, 1 Well, 10/Box
For use with 8 channel pipets.
..., manually adjustable dispensing head, and disposa...ings unparalleled flexibility and cost-efficiency ...strument of its kind to offer fast dispensing of f...L). It also offers the added benefit of being able...
...ted non-contact dispensing technique that couples ...e and stage stepper motor. synQUAD dispenses a pre...s, plates, or membranes. At 100 nL dispense volume... than 10%. An 8-channel synQUAD system dispenses 1...
Medicine Products:(Date:8/27/2008)... The American Society for Therapeutic Radiology an...ist Audrey Evans, M.D., as its 2008 honorary membe...Ceremony held Tuesday, September 23, at 10:00 a.m....r. Evans has been on the forefront of the treatmen...as one of the co-founders of the original Ronald M...
(Date:8/27/2008)...inding could lead to new drugs in fight against ob... (HealthDay News) -- A chemical produced in the br... likelihood of becoming obese, according to a new ...a group of 33 people who had WAGR syndrome, a gene...illion people. WAGR is an acronym for the symptoms...
(Date:8/27/2008)...dding Velcade to standard drug therapy prolonged s... 27 (HealthDay News) -- Patients with multiple mye... lived longer and better by adding the drug Velcad...he finding could make multiple myeloma, a cancer o...a lethal disease. And it would be particularly val...
(Date:8/27/2008)...tudy also uncovers risks associated with treating ...DAY, Aug. 27 (HealthDay News) -- Scientists from t...st gene directly associated with the onset of seve... age-related macular degeneration that currently t...ericans. , The discovery, based on work with bo...
Breaking Medicine News(10 mins):Health News:ASTRO selects pediatric oncologist as 2008 honorary member 2Health News:Low Levels of Brain Chemical May Control Appetite 2Health News:Combination Therapy Helps to Combat Myeloma 2Health News:Combination Therapy Helps to Combat Myeloma 3Health News:Gene Linked to 'Dry' Macular Degeneration 2Health News:Gene Linked to 'Dry' Macular Degeneration 3(Date:8/28/2008)...Aug. 28 /- Intercell AG (VSE: ICLL) t...Inc. has initiated a Phase II,clinical trial of V7...of,Staphylococcus aureus (S. aureus) infections. T...udy aims to evaluate the safety and immunogenicity...ge kidney disease on,hemodialysis. This trial star...
(Date:8/27/2008)...VELCADE, melphalan and prednisone arm demonstrated...percent complete response -, CAMBRIDGE, Mass., Au...ogy Company today announced the publication of res...ISTA(1) trial in this week,s edition of the,New En...gnificant survival,benefit and a 30 percent comple...
(Date:8/27/2008)...data, from BLISS-52 trial, expected by mid-2009 - ...ted by fall 2009 -, ROCKVILLE, Md., Aug. 27 /PRNe...Nasdaq: HGSI ) today announced it has completed e...nd of two pivotal Phase 3,randomized clinical tria...,active systemic lupus erythematosus (SLE). Belimu...
(Date:8/26/2008).... 26 /- Semafore Pharmaceuticals Inc....ess on Targeted Therapies,in Cancer in Washington,...geted kinase inhibitors that demonstrate significa... novel and proprietary molecular scaffold has been...or the design of pan-PI3 kinase inhibitors,as well...
Breaking Medicine Technology:Intercell Announces Initiation of Further Phase II Clinical Trial of V710 an Investigational Vaccine to Prevent S. aureus Infection 2Intercell Announces Initiation of Further Phase II Clinical Trial of V710 an Investigational Vaccine to Prevent S. aureus Infection 3New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 2New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 3New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 4New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 5New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 6Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 2Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 3Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 4Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 5Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 6Semafore Broadens Pipeline With Multi-Targeted Kinase Inhibitors 2Semafore Broadens Pipeline With Multi-Targeted Kinase Inhibitors 3SuperGen to Present at FBR Capital Markets 12th Annual Spring Investor Conference on May 29 2008 5581 1SuperGen to Present at FBR Capital Markets 12th Annual Spring Investor Conference on May 29 2008 5581 2Advance Nanotechs Owlstone Subsidiary Selected as One of Four Finalists in The 2008 Royal Academy of Engineering MacRobert Awards Competition 5579 1Advance Nanotechs Owlstone Subsidiary Selected as One of Four Finalists in The 2008 Royal Academy of Engineering MacRobert Awards Competition 5579 2Advance Nanotechs Owlstone Subsidiary Selected as One of Four Finalists in The 2008 Royal Academy of Engineering MacRobert Awards Competition 5579 3Advance Nanotechs Owlstone Subsidiary Selected as One of Four Finalists in The 2008 Royal Academy of Engineering MacRobert Awards Competition 5579 4BioMarin to Host Research and Development Day June 5th 5577 1BioMarin to Host Research and Development Day June 5th 5577 2Ardea Announces Progress with HIV Non Nucleoside Reverse Transcriptase Inhibitor Program 2172 1Ardea Announces Progress with HIV Non Nucleoside Reverse Transcriptase Inhibitor Program 2172 2Ardea Announces Progress with HIV Non Nucleoside Reverse Transcriptase Inhibitor Program 2172 3Ardea Announces Progress with HIV Non Nucleoside Reverse Transcriptase Inhibitor Program 2172 4...xpressed protein,protects human pancreatic cancer ...ving one of the body,s natural defenses against,ou...rsity of Texas,M. D. Anderson Cancer Center report..., The protein tissue transglutaminase, known by th...esearchers at M. D. Anderson and,elsewhere to be o...
...ill Suffering from Chronic,Hepatitis B and C, NEW ...or Disease,Control and Prevention (CDC) has report...ute hepatitis infections in the United States,in t...tis A and B,vaccination programs. The American Liv...sults, but remind people that chronic,hepatitis B ...
Other Medicine Technology:Protein Found to Shield Pancreatic Cancer Cells from,Self-Destruction 2Protein Found to Shield Pancreatic Cancer Cells from,Self-Destruction 3The American Liver Foundation Urges Cautious Optimism about CDC,Report on Declining Acute Hepatitis Infection Rates 2The American Liver Foundation Urges Cautious Optimism about CDC,Report on Declining Acute Hepatitis Infection Rates 3